ALXO

2.125

3.16% 0.065

Handel nachbörslich: 2.12 -0.005 -0.24%

Alx Oncology Holdings Inc (ALXO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$2.06

Offen:

$2.08

24-Stunden-Volumen:

780.72K

Relative Volume:

0.55

Marktkapitalisierung:

$285.95M

Einnahmen:

Nettoeinkommen (Verlust:

$-101.70M

KGV:

-1.1207

EPS:

-1.8961

Netto-Cashflow:

$-84.35M

1W Leistung:

+2.66%

1M Leistung:

+45.55%

6M Leistung:

+57.41%

1J Leistung:

+327.57%

1-Tages-Spanne:

$2.00

$2.17

1-Wochen-Bereich:

$2.00

$2.41

52-Wochen-Spanne:

$0.444

$2.66

Alx Oncology Holdings Inc Stock (ALXO) Company Profile

Firmenname

Alx Oncology Holdings Inc

Sektor

Healthcare (1096)

Branche

Biotechnology (616)

Telefon

650-466-7125

Adresse

323 ALLERTON AVENUE, SOUTH SAN FRANCISCO

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-08-11

Neueste SEC-Einreichungen

ALXO's Discussions on Twitter

Compare ALXO vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ALXO Alx Oncology Holdings Inc	2.125	285.95M	0	-101.70M	-84.35M	-1.8961
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Alx Oncology Holdings Inc Stock (ALXO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-03-19	Eingeleitet	Wells Fargo	Overweight
2026-03-06	Fortgesetzt	UBS	Buy
2025-11-13	Eingeleitet	Jefferies	Buy
2025-03-06	Hochstufung	Jefferies	Hold → Buy
2024-12-19	Herabstufung	Jefferies	Buy → Hold
2024-03-08	Herabstufung	Stifel	Buy → Hold
2023-12-08	Hochstufung	Jefferies	Hold → Buy
2021-12-22	Herabstufung	Jefferies	Buy → Hold
2021-09-30	Eingeleitet	Stifel	Buy
2021-05-05	Fortgesetzt	Credit Suisse	Outperform
2021-04-26	Fortgesetzt	Credit Suisse	Outperform
2021-04-06	Eingeleitet	UBS	Buy
2021-02-10	Eingeleitet	H.C. Wainwright	Buy
2020-08-11	Eingeleitet	Cantor Fitzgerald	Overweight
2020-08-11	Eingeleitet	Credit Suisse	Outperform
2020-08-11	Eingeleitet	Jefferies	Buy
2020-08-11	Eingeleitet	Piper Sandler	Overweight

Alle ansehen

Alx Oncology Holdings Inc Aktie (ALXO) Neueste Nachrichten

Jul 09, 2026

BIAF Stock Plunges 77% in 3 Months: Should You Still Hold or Sell? - The Globe and Mail

Jul 09, 2026

Jul 06, 2026

ALX Oncology (ALXO) SVP sells 1,404 shares for RSU tax obligations - Stock Titan

Jul 06, 2026

Jul 05, 2026

ALXOAlx Oncology Holdings Inc Options - Finviz

Jul 05, 2026

Jun 30, 2026

ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules - The Manila Times

Jun 30, 2026

Leadership shifts at ALX Oncology (NASDAQ: ALXO) as Garland becomes chair - Stock Titan

Jun 30, 2026

ALX Oncology names Scott Garland chairman, adds general counsel - Investing.com UK

Jun 30, 2026

ALX Oncology names Scott Garland chairman, adds general counsel By Investing.com - Investing.com India

Jun 30, 2026

ALXO Welcomes New Leadership with Board Changes - GuruFocus

Jun 30, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jun 30, 2026

ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel - Investing News Network

Jun 30, 2026

ALX Oncology appoints Scott Garland as chairman and Michael Listgarten as general counsel to strengthen leadership - Traders Union

Jun 30, 2026

Jun 29, 2026

ALX Oncology Holdings Inc.(NasdaqGS:ALXO) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com

Jun 29, 2026

ALX Oncology Holdings Inc.(NasdaqGS: ALXO) added to Russell 2500 Growth Benchmark - marketscreener.com

Jun 29, 2026

ALX Oncology Holdings Inc.(NasdaqGS: ALXO) added to Russell 2000 Index - marketscreener.com

Jun 29, 2026